Neonatal Encephalopathy clinical trials at UCSF
1 in progress, 0 open to eligible people
Sorry, in progress, not accepting new patients
Hypoxic-ischemic encephalopathy (HIE) occurs when a baby gets reduced blood flow and oxygen to the brain near the time of birth. This results in death or neurologic disabilities including cerebral palsy and cognitive impairment in up to half of affected infants. This clinical trial will determine if the drug erythropoietin (Epo) added to hypothermia (usual therapy) will improve outcomes for infants suffering from HIE.
San Francisco, California and other locations